The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Amanda B. Spurdle

Queensland Institute of Medical Research

Brisbane

Australia

[email]@qimr.edu.au

Name/email consistency: low

 
 
 
 
 
 
 

Affiliations

  • Queensland Institute of Medical Research, Brisbane, Australia. 2005
  • Cancer Unit, Joint Experimental Oncology Programme, Queensland Institute of Medical Research, and The University of Queensland, Australia. 1999 - 2003
  • Oncology Division, The Queensland Institute of Medical Research, PO Royal Brisbane Hospital, Herston, Australia. 2001

References

  1. The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Spurdle, A.B., Antoniou, A.C., Duffy, D.L., Pandeya, N., Kelemen, L., Chen, X., Peock, S., Cook, M.R., Smith, P.L., Purdie, D.M., Newman, B., Dite, G.S., Apicella, C., Southey, M.C., Giles, G.G., Hopper, J.L., Chenevix-Trench, G., Easton, D.F. Breast Cancer Res. (2005) [Pubmed]
  2. The prohibitin 3' untranslated region polymorphism is not associated with risk of ovarian cancer. Spurdle, A.B., Purdie, D.M., Chen, X., Chenevix-Trench, G. Gynecol. Oncol. (2003) [Pubmed]
  3. The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years. Spurdle, A.B., Hopper, J.L., Chen, X., Dite, G.S., Cui, J., McCredie, M.R., Giles, G.G., Ellis-Steinborner, S., Venter, D.J., Newman, B., Southey, M.C., Chenevix-Trench, G. Cancer Epidemiol. Biomarkers Prev. (2002) [Pubmed]
  4. The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women. Spurdle, A.B., Hopper, J.L., Chen, X., McCredie, M.R., Giles, G.G., Venter, D.J., Southey, M.C., Chenevix-Trench, G. Cancer Epidemiol. Biomarkers Prev. (2002) [Pubmed]
  5. The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer. Spurdle, A.B., Goodwin, B., Hodgson, E., Hopper, J.L., Chen, X., Purdie, D.M., McCredie, M.R., Giles, G.G., Chenevix-Trench, G., Liddle, C. Pharmacogenetics (2002) [Pubmed]
  6. Prohibitin 3' untranslated region polymorphism and breast cancer risk in Australian women. Spurdle, A.B., Hopper, J.L., Chen, X., McCredie, M.R., Giles, G.G., Newman, B., Chenevix-Trench, G. Lancet (2002) [Pubmed]
  7. No evidence for association of ataxia-telangiectasia mutated gene T2119C and C3161G amino acid substitution variants with risk of breast cancer. Spurdle, A.B., Hopper, J.L., Chen, X., McCredie, M.R., Giles, G.G., Newman, B., Chenevix-Trench, G., Khanna, K. Breast Cancer Res. (2002) [Pubmed]
  8. Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype. Spurdle, A.B., Webb, P.M., Purdie, D.M., Chen, X., Green, A., Chenevix-Trench, G. Carcinogenesis (2001) [Pubmed]
  9. No significant association between progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of ovarian cancer. Spurdle, A.B., Webb, P.M., Purdie, D.M., Chen, X., Green, A., Chenevix-Trench, G. Carcinogenesis (2001) [Pubmed]
  10. Androgen receptor exon 1 CAG repeat length and risk of ovarian cancer. Spurdle, A.B., Webb, P.M., Chen, X., Martin, N.G., Giles, G.G., Hopper, J.L., Chenevix-Trench, G. Int. J. Cancer (2000) [Pubmed]
  11. CYP17 promoter polymorphism and breast cancer in Australian women under age forty years. Spurdle, A.B., Hopper, J.L., Dite, G.S., Chen, X., Cui, J., McCredie, M.R., Giles, G.G., Southey, M.C., Venter, D.J., Easton, D.F., Chenevix-Trench, G. J. Natl. Cancer Inst. (2000) [Pubmed]
  12. Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years. Spurdle, A.B., Dite, G.S., Chen, X., Mayne, C.J., Southey, M.C., Batten, L.E., Chy, H., Trute, L., McCredie, M.R., Giles, G.G., Armes, J., Venter, D.J., Hopper, J.L., Chenevix-Trench, G. J. Natl. Cancer Inst. (1999) [Pubmed]
 
WikiGenes - Universities